← Leaderboards
William B. Guggino
Johns Hopkins University
$17,014,421
Attributed
$18,691,457
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$38,871,161 · 11
By mechanism
P01$28,029,093 · 8
R01$10,842,068 · 3
Top collaborators
- Liudmila Cebotaru5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Pamela L. Zeitlin$9,680,949
- Steven D Gore$7,773,366
- Hugo W Moser$5,176,943
- Michael A. Carducci$23,642,506
- Andrew P Lane$17,085,410
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGene ExpressionGenesProteinsBudgetsGene TherapyGrantLeadVoltage /Patch ClampTherapeutic AgentsAffectProgramsGene TransferChloride ChannelsIon TransportLungRegulationAreaCell MembraneXenopus OocyteBinding (Molecular Function)InstructionAbbreviations
Grant awards (79)
CF Gene Therapy with adeno-associated viral vectors$726,898
R01 · FY2020 · HL
CF Gene Therapy with adeno-associated viral vectors$723,820
R01 · FY2019 · HL
CF Gene Therapy with adeno-associated viral vectors$723,820
R01 · FY2018 · HL
CF Gene Therapy with adeno-associated viral vectors$664,618
R01 · FY2017 · HL
CF Gene Therapy with adeno-associated viral vectors$514,916
R01 · FY2016 · HL
Gene and Pharmacological Therapies for Cystic Fibrosis$1,056,163
P01 · FY2013 · HL · contact PI
Outward Trafficking of CFTR$355,008
P01 · FY2013 · DK · contact PI
Repeat dosing of adeno-associated viral vectors$176,029
P01 · FY2013 · HL · contact PI
Administrative Core$176,025
P01 · FY2013 · HL · contact PI
Expression Core$176,025
P01 · FY2013 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,114,184
P01 · FY2012 · HL · contact PI
Outward Trafficking of CFTR$368,863
P01 · FY2012 · DK · contact PI
Administrative Core$185,698
P01 · FY2012 · HL · contact PI
Expression Core$185,697
P01 · FY2012 · HL · contact PI
Repeat dosing of adeno-associated viral vectors$185,697
P01 · FY2012 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,139,310
P01 · FY2011 · HL · contact PI
Outward Trafficking of CFTR$359,139
P01 · FY2011 · DK · contact PI
Mechanisms of Transport in Proximal and Distal Tubules$341,564
R01 · FY2011 · DK · contact PI
Administrative Core$189,885
P01 · FY2011 · HL · contact PI
Expression Core$189,885
P01 · FY2011 · HL · contact PI
Repeat dosing of adeno-associated viral vectors$189,885
P01 · FY2011 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,143,824
P01 · FY2010 · HL · contact PI
Outward Trafficking of CFTR$379,318
P01 · FY2010 · DK · contact PI
Mechanisms of Transport in Proximal and Distal Tubules$345,015
R01 · FY2010 · DK · contact PI
Administrative Core$190,638
P01 · FY2010 · HL · contact PI
Expression Core$190,638
P01 · FY2010 · HL · contact PI
Repeat dosing of adeno-associated viral vectors$190,637
P01 · FY2010 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,163,621
P01 · FY2009 · HL · contact PI
CFTR/Regulation of CL Secretion in Normal and CF Airways$398,110
R01 · FY2009 · HL · contact PI
Outward Trafficking of CFTR$358,983
P01 · FY2009 · DK · contact PI
Mechanisms of Transport in Proximal and Distal Tubules$348,500
R01 · FY2009 · DK · contact PI
Administrative Core$193,937
P01 · FY2009 · HL · contact PI
Expression Core$193,937
P01 · FY2009 · HL · contact PI
Repeat dosing of adeno-associated viral vectors$193,936
P01 · FY2009 · HL · contact PI
Mechanisms of Transport in Proximal and Distal Tubules$16,400
R01 · FY2009 · DK · contact PI
CFTR/Regulation of CL Secretion in Normal and CF Airways$8,200
R01 · FY2009 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,554,185
P01 · FY2008 · HL · contact PI
Repeat Dosing of Adeno-Associated Viral Vectors$454,495
P01 · FY2008 · HL · contact PI
CFTR/Regulation of CL Secretion in Normal and CF Airways$398,110
R01 · FY2008 · HL · contact PI
Mechanisms of Transport in Proximal and Distal Tubules$348,500
R01 · FY2008 · DK · contact PI
Core--Expression$166,338
P01 · FY2008 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,542,765
P01 · FY2007 · HL · contact PI
Repeat Dosing of Adeno-Associated Viral Vectors$449,827
P01 · FY2007 · HL · contact PI
CFTR/Regulation of CL Secretion in Normal and CF Airways$398,110
R01 · FY2007 · HL · contact PI
Core--Expression$164,624
P01 · FY2007 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,545,724
P01 · FY2006 · HL · contact PI
CFTR/Regulation of CL Secretion in Normal and CF Airways$408,750
R01 · FY2006 · HL · contact PI
Repeat Dosing of Adeno-Associated Viral Vectors$309,362
P01 · FY2006 · HL · contact PI
Mechanisms of Transport in Proximal and Distal Tubules$278,405
R01 · FY2006 · DK · contact PI
Core--Expression$113,209
P01 · FY2006 · HL · contact PI
Gene and Pharmacological Therapies for Cystic Fibrosis$1,539,737
P01 · FY2005 · HL
Repeat Dosing of Adeno-Associated Viral Vectors$300,350
P01 · FY2005 · HL
Mechanisms of Transport in Proximal and Distal Tubules$285,105
R01 · FY2005 · DK
Core--Expression$109,911
P01 · FY2005 · HL
Gene and Pharmacological Therapies for Cystic Fibrosis$1,522,120
P01 · FY2004 · HL
CFTR/REGULATION OF CL SECRETION IN NORMAL AND CF AIRWAYS$455,446
R01 · FY2004 · HL
Repeat Dosing of Adeno-Associated Viral Vectors$291,602
P01 · FY2004 · HL
Mechanisms of Transport in Proximal and Distal Tubules$285,105
R01 · FY2004 · DK
Administrative$211,156
P01 · FY2004 · HL
Core--Expression$106,709
P01 · FY2004 · HL
GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS$1,787,287
P01 · FY2003 · HL
CFTR/REGULATION OF CL SECRETION IN NORMAL AND CF AIRWAYS$444,772
R01 · FY2003 · HL
Mechanisms of Transport in Proximal and Distal Tubules$351,321
R01 · FY2003 · DK
GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS$1,737,446
P01 · FY2002 · HL
CFTR/REGULATION OF CL SECRETION IN NORMAL AND CF AIRWAYS$434,406
R01 · FY2002 · HL
MECHANISMS OF TRANSPORT IN PROXIMAL AND DISTAL TUBULES$351,232
R01 · FY2002 · DK
CORE--EXPRESSION$0
P01 · FY2002 · HL
REPEAT DOSING OF ADENO-ASSOCIATED VIRAL VECTORS$0
P01 · FY2002 · HL
GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS$1,689,320
P01 · FY2001 · HL
CFTR/REGULATION OF CL SECRETION IN NORMAL AND CF AIRWAYS$423,758
R01 · FY2001 · HL
MECHANISMS OF TRANSPORT IN PROXIMAL AND DISTAL TUBULES$341,001
R01 · FY2001 · DK
MECHANISMS OF TRANSPORT IN PROXIMAL AND DISTAL TUBULES$81,750
R01 · FY2001 · DK
CORE--EXPRESSION$0
P01 · FY2001 · HL
REPEAT DOSING OF ADENO-ASSOCIATED VIRAL VECTORS$0
P01 · FY2001 · HL
GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS$1,644,018
P01 · FY2000 · HL
CFTR/REGULATION OF CL SECRETION IN NORMAL AND CF AIRWAYS$412,357
R01 · FY2000 · HL
MECHANISMS OF TRANSPORT IN PROXIMAL AND DISTAL TUBULES$332,079
R01 · FY2000 · DK
CORE--EXPRESSION$270,973
P01 · FY2000 · HL
REPEAT DOSING OF ADENO-ASSOCIATED VIRAL VECTORS$270,973
P01 · FY2000 · HL